Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transrenal DNA testing: progress and perspectives.

Samuil R Umansky1, L David Tomei

  • 1Xenomics Inc., Monmouth Junction, NJ 08852, USA. sumansky@xenomics.com

Expert Review of Molecular Diagnostics
|March 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of long-term COVID-19.

Aging·2021
Same author

Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome.

PloS one·2019
Same author

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.

Alzheimer's research & therapy·2017
Same author

Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study.

Aging·2013
Same author

Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study.

Journal of translational medicine·2013
Same author

Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies.

Frontiers in cellular neuroscience·2013
Same journal

Bacterial respiratory infections: advances in diagnostic strategies.

Expert review of molecular diagnostics·2026
Same journal

Artificial intelligence in molecular diagnostics for pandemic preparedness.

Expert review of molecular diagnostics·2026
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
See all related articles

Transrenal DNA (Tr-DNA), extracellular DNA from dying cells, crosses the kidney barrier into urine. This noninvasive biomarker shows promise for prenatal testing, cancer diagnostics, and infectious disease detection.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Extracellular DNA is found in circulation, but a fraction crosses the kidney barrier into urine.
  • Transrenal DNA (Tr-DNA) consists of 150-200 bp fragments originating from apoptotic cells throughout the body.

Purpose of the Study:

  • To review the applications, advantages, and challenges of Transrenal DNA (Tr-DNA) technology.
  • To highlight the diagnostic potential of Tr-DNA in various medical fields.

Main Methods:

  • Detection of fetal DNA sequences in pregnant women's urine.
  • Identification of tumor-specific mutations in Tr-DNA from cancer patients.
  • Analysis of donor DNA in recipient urine post-transplantation.
  • Detection of viral (HIV), bacterial, and parasitic DNA in Tr-DNA.

Related Experiment Videos

Main Results:

  • Tr-DNA has been successfully isolated and analyzed from human urine.
  • Fetal, tumor-specific, donor, and pathogen DNA sequences have been identified in Tr-DNA.
  • Demonstrated potential for noninvasive molecular diagnostics.

Conclusions:

  • Tr-DNA represents a versatile, noninvasive biomarker with broad diagnostic applications.
  • Potential uses include prenatal screening, cancer detection, infectious disease diagnosis, and monitoring of transplantation and treatment.
  • Further development is needed to address potential challenges in Tr-DNA test implementation.